GenusPlus Group Ltd (ASX:GNP) posted a 70.5% year-over-year revenue increase to $1.281 billion for the fiscal year ended June 30, 2026, while normalized EBITDA rose 49.6% to $100.8 million, surpassing the $100 million threshold for the first time.
Underlying net profit after tax, excluding acquisition-related costs and amortization, climbed 44.0% to $54.7 million, with basic earnings per share up 35.5% at 26.75 cents. Operating cash flow surged 60.4% to $194.0 million, while the company’s cash balance increased to $476.0 million and its net cash position improved to $399.3 million.
The infrastructure segment delivered the strongest performance, with revenue jumping 101.5% to $837.4 million and EBITDA rising 67.6% to $55.3 million. Key projects included the HumeLink East transmission line, TasNetworks’ North West Transmission Development, and Western Power’s Clean Energy Link, which secured an additional $110 million in work packages. The energy and engineering segment reported revenue growth of 57.2% to $368.7 million, though EBITDA remained flat at $20.7 million. The services segment grew revenue by 23.5% to $152.2 million, with normalized EBITDA up 49.2% to $22.8 million.
GenusPlus completed two acquisitions in FY2026: MPC Kinetic (MPK) on July 1, adding approximately 900 workers and onshore gas gathering assets in Queensland’s Surat basin, and Railtrain Group Holdings on March 31. The MPK deal was structured at roughly 4.3x FY27 EBITDA, assuming the top-end earn-out target. Recurring revenue grew at a compound annual rate of 47.5% to $446 million, up from $64 million in FY2021.
The company declared a final dividend of 3.6 cents per share, bringing total FY2026 dividends to 5.6 cents, a 55.6% increase from the prior year. Cash balances rose to $476.0 million, while net tangible assets increased to $295.5 million and total net assets reached $398.1 million. GenusPlus also completed a $200 million equity raise and expanded its revolving credit facility to $549 million.
Management guided for normalized EBITDA of $200–205 million in FY2027, representing approximately 100% growth from FY2026. The orderbook stands at $2.2 billion, with a tendered pipeline of $3.6 billion. Capital expenditure is projected at $65–70 million for FY2027, including requirements from the MPK and Railtrain acquisitions.
Shares of GenusPlus slipped 1.9% to $8.76 following the results announcement, after a 92% rally over the prior 12 months. The company’s 52-week range is $4.55 to $11.35, with a beta of 0.63. Founder and Managing Director David Riches and related entities hold a 45.6% stake in the company.
